Previous research demonstrated that aberrant FOXM1 expression drove the proliferation, invasion, and metastasis of breast cancer cells, with modulation of its ubiquitination levels serving as a potential regulatory mechanism influencing these malignant behaviors and, consequently, impacting disease progression and patient prognosis [27, 28]. This evidence concerns the gene FOXM1 and breast carcinoma.